\-\ Texto\\:\\ \ \(0\)\
\-\ vitals\\ within\\ normal\\ range\\,\\ normal\\ labs\ \(0\)\
\-\ majority\\ of\\ patients\\ are\\ asymptomatic\\ and\\ hence\\ no\\ further\\ action\\ is\\ necessary\\.\\ \\ larger\\ lesion\\ may\\ require\\ closer\\ follow\\ up\\ as\\ mass\\ effect\\ may\\ cause\\ various\\ symptoms\\.\\ \\ in\\ those\\ cases\\,\\ surgical\\ resection\\ may\\ be\\ considered\\.\ \(0\)\
\-\ solitary\\ left\\ adrenal\\ mass\\ measuring\\ 2\\.8cm\\ in\\ diameter\ \(1\)\
\-\ focal\\ areas\\ of\\ hypodensity\\ within\\ a\\ circumscrimed\\ higher\\ attenuation\\ mass\\.\\ \ \(1\)\
\-\ no\\ areas\\ of\\ calcification\ \(1\)\
\-\ adrenal\\ myelolipoma\ \(1\)\
\-\ adrenal\\ adenoma\ \(7\)\
\-\ adrenal\\ carcinoma\ \(2\)\
\-\ angiomyolipoma\ \(35\)\
\-\ liposarcoma\ \(53\)\
\-\ adrenal\\ myelolipoma\ \(1\)\
\-\ 68\\ yo\\ male\\ with\\ history\\ of\\ gross\\ hematuria\\ with\\ no\\ other\\ complaints\ \(1\)\
\-\ the\\ etiology\\ of\\ this\\ patient\\'s\\ episode\\ of\\ gross\\ hematuria\\ is\\ unclear\\,\\ and\\ there\\ is\\ no\\ indication\\ that\\ there\\ may\\ have\\ been\\ hemorrhage\\ within\\ the\\ adrenal\\ myelolipoma\\ as\\ there\\ are\\ no\\ areas\\ of\\ acute\\ bleeding\\ or\\ calcification\\ present\\.\\ \\ hence\\ it\\ is\\ reasonable\\ that\\ the\\ cause\\ of\\ hematuria\\ be\\ extra\\-adrenal\\.\\ \\ the\\ size\\ of\\ this\\ patient\\'s\\ adrenal\\ mass\\ does\\ not\\ appear\\ to\\ interrupt\\ the\\ architecture\\ of\\ other\\ surrounding\\ organs\\.\\ \\ prognosis\\ of\\ this\\ patient\\ is\\ good\\ in\\ terms\\ of\\ the\\ adrenal\\ mass\\ as\\ he\\ has\\ been\\ asymptomatic\\ with\\ normal\\ hormonal\\ labs\\.\\ \\ follow\\ up\\ imaging\\ may\\ be\\ indicated\\ to\\ monitor\\ the\\ growth\\ of\\ the\\ mass\\.\ \(0\)\
\-\ Keywords\\ by\\ value\\:\\ \ \(0\)\
\-\ adrenal\\:\\ 0\\.17394500720540135\ \(0\)\
\-\ myelolipoma\\:\\ 0\\.09109944273959875\ \(0\)\
\-\ hematuria\\:\\ 0\\.0611056958166142\ \(0\)\
\-\ hence\\:\\ 0\\.0562476643125457\ \(0\)\
\-\ may\\:\\ 0\\.047093677610505626\ \(0\)\
\-\ \\-solitary\\:\\ 0\\.044299087557620596\ \(0\)\
\-\ circumscrimed\\:\\ 0\\.044299087557620596\ \(0\)\
\-\ areas\\:\\ 0\\.043346942280091456\ \(0\)\
\-\ gross\\:\\ 0\\.040910415031188425\ \(0\)\
\-\ extra\\-adrenal\\:\\ 0\\.04081593589651534\ \(0\)\
\-\ interrupt\\:\\ 0\\.04081593589651534\ \(0\)\
\-\ 2\\.8cm\\:\\ 0\\.03877842279044416\ \(0\)\
\-\ mass\\:\\ 0\\.035832995184348675\ \(0\)\
\-\ action\\:\\ 0\\.03224936256868406\ \(0\)\
\-\ calcification\\:\\ 0\\.031173724808614363\ \(0\)\
\-\ hormonal\\:\\ 0\\.030690795089770292\ \(0\)\
\-\ closer\\:\\ 0\\.030366480913199583\ \(0\)\
\-\ \\-no\\:\\ 0\\.030366480913199583\ \(0\)\
\-\ labs\\:\\ 0\\.02986908549683556\ \(0\)\
\-\ architecture\\:\\ 0\\.029502911782914865\ \(0\)\
\-\ cause\\:\\ 0\\.02905791584474338\ \(0\)\
\-\ asymptomatic\\:\\ 0\\.029031079376845098\ \(0\)\
\-\ reasonable\\:\\ 0\\.028328967807128402\ \(0\)\
\-\ terms\\:\\ 0\\.027737093256091302\ \(0\)\
\-\ unclear\\:\\ 0\\.02737800298482424\ \(0\)\
\-\ follow\\:\\ 0\\.02728843690398426\ \(0\)\
\-\ indication\\:\\ 0\\.027207643428665038\ \(0\)\
\-\ hypodensity\\:\\ 0\\.02643301689686977\ \(0\)\
\-\ angiomyolipoma\\:\\ 0\\.025889230039381168\ \(0\)\
\-\ liposarcoma\\:\\ 0\\.025889230039381168\ \(0\)\
\-\ organs\\:\\ 0\\.0246406804951676\ \(0\)\
\-\ within\\:\\ 0\\.024574845352553994\ \(0\)\
\-\ monitor\\:\\ 0\\.024443591484347087\ \(0\)\
\-\ 68\\:\\ 0\\.024347871911630035\ \(0\)\
\-\ various\\:\\ 0\\.02372449176755979\ \(0\)\
\-\ been\\:\\ 0\\.023364772758432073\ \(0\)\
\-\ up\\:\\ 0\\.02309394121662536\ \(0\)\
\-\ episode\\:\\ 0\\.021259049976361438\ \(0\)\
\-\ majority\\:\\ 0\\.021107527171483613\ \(0\)\
\-\ higher\\:\\ 0\\.021058018144131795\ \(0\)\
\-\ larger\\:\\ 0\\.020678583206904935\ \(0\)\
\-\ vitals\\:\\ 0\\.02054336987564903\ \(0\)\
\-\ prognosis\\:\\ 0\\.020368565272204733\ \(0\)\
\-\ normal\\:\\ 0\\.02019516263214725\ \(0\)\
\-\ be\\:\\ 0\\.01986567924639089\ \(0\)\
\-\ other\\:\\ 0\\.019795362298517073\ \(0\)\
\-\ require\\:\\ 0\\.019649465555417432\ \(0\)\
\-\ those\\:\\ 0\\.0195390187879864\ \(0\)\
\-\ as\\:\\ 0\\.019486093053680317\ \(0\)\
\-\ there\\:\\ 0\\.019171591303492292\ \(0\)\
\-\ necessary\\:\\ 0\\.019020505038060617\ \(0\)\
\-\ \\'s\\:\\ 0\\.01893514189313613\ \(0\)\
\-\ growth\\:\\ 0\\.018671618071066834\ \(0\)\
\-\ complaints\\:\\ 0\\.018641070100833757\ \(0\)\
\-\ bleeding\\:\\ 0\\.018641070100833757\ \(0\)\
\-\ indicated\\:\\ 0\\.018580525686179614\ \(0\)\
\-\ good\\:\\ 0\\.01837418655654256\ \(0\)\
\-\ etiology\\:\\ 0\\.01817598689799333\ \(0\)\
\-\ diameter\\:\\ 0\\.018066143713005897\ \(0\)\
\-\ adenoma\\:\\ 0\\.01793213242113574\ \(0\)\
\-\ appear\\:\\ 0\\.01757486648302654\ \(0\)\
\-\ considered\\:\\ 0\\.017334383964545962\ \(0\)\
\-\ no\\:\\ 0\\.017295359813141748\ \(0\)\
\-\ range\\:\\ 0\\.017287638272775543\ \(0\)\
\-\ attenuation\\:\\ 0\\.017264427489578085\ \(0\)\
\-\ measuring\\:\\ 0\\.01717264182135048\ \(0\)\
\-\ effect\\:\\ 0\\.015203810316930879\ \(0\)\
\-\ that\\:\\ 0\\.01483397717144546\ \(0\)\
\-\ does\\:\\ 0\\.014651362162733701\ \(0\)\
\-\ this\\:\\ 0\\.014489505728353764\ \(0\)\
\-\ size\\:\\ 0\\.014396361162707394\ \(0\)\
\-\ cases\\:\\ 0\\.014305582231060968\ \(0\)\
\-\ hemorrhage\\:\\ 0\\.014292746654150933\ \(0\)\
\-\ is\\:\\ 0\\.014127909004641349\ \(0\)\
\-\ surrounding\\:\\ 0\\.014116408363642037\ \(0\)\
\-\ further\\:\\ 0\\.013655498200001297\ \(0\)\
\-\ resection\\:\\ 0\\.013391535957388033\ \(0\)\
\-\ yo\\:\\ 0\\.012921364438707346\ \(0\)\
\-\ patient\\:\\ 0\\.012913446194719416\ \(0\)\
\-\ focal\\:\\ 0\\.012263786955469357\ \(0\)\
\-\ carcinoma\\:\\ 0\\.012170490804099833\ \(0\)\
\-\ he\\:\\ 0\\.011980840914738791\ \(0\)\
\-\ are\\:\\ 0\\.011707275100800017\ \(0\)\
\-\ patients\\:\\ 0\\.011113440197819225\ \(0\)\
\-\ symptoms\\:\\ 0\\.010701796366322307\ \(0\)\
\-\ acute\\:\\ 0\\.010602408688977364\ \(0\)\
\-\ imaging\\:\\ 0\\.010060672484701522\ \(0\)\
\-\ present\\:\\ 0\\.009698536451917995\ \(0\)\
\-\ it\\:\\ 0\\.00965250444488953\ \(0\)\
\-\ have\\:\\ 0\\.009298683810879858\ \(0\)\
\-\ \\-\\:\\ 0\\.009204665621650069\ \(0\)\
\-\ surgical\\:\\ 0\\.009026240051514842\ \(0\)\
\-\ lesion\\:\\ 0\\.00874650867336912\ \(0\)\
\-\ has\\:\\ 0\\.008063818947207427\ \(0\)\
\-\ male\\:\\ 0\\.007764851949183282\ \(0\)\
\-\ of\\:\\ 0\\.007610801057155023\ \(0\)\
\-\ in\\:\\ 0\\.006352722062415903\ \(0\)\
\-\ not\\:\\ 0\\.006205118953477062\ \(0\)\
\-\ history\\:\\ 0\\.005930726320136097\ \(0\)\
\-\ the\\:\\ 0\\.005557760189090485\ \(0\)\
\-\ or\\:\\ 0\\.005032777632983455\ \(0\)\
\-\ left\\:\\ 0\\.004804549091823692\ \(0\)\
\-\ to\\:\\ 0\\.004292141793396847\ \(0\)\
\-\ \\,\\:\\ 0\\.004081056264079709\ \(0\)\
\-\ a\\:\\ 0\\.0019929638282341774\ \(0\)\
\-\ and\\:\\ 0\\.0018091357360021955\ \(0\)\
\-\ with\\:\\ 0\\.0017638820516063778\ \(0\)\
\-\ \\.\\:\\ 0\\.0016055066576689272\ \(0\)\
